Michael Gormley
Overview
Explore the profile of Michael Gormley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
746
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Besse B, Goto K, Wang Y, Lee S, Marmarelis M, Ohe Y, et al.
J Thorac Oncol
. 2025 Jan;
PMID: 39755170
Introduction: Treatment options for patients with EGFR-mutated NSCLC with disease progression on or after osimertinib and platinum-based chemotherapy are limited. Methods: CHRYSALIS-2 cohort A evaluated amivantamab plus lazertinib in patients...
2.
Sicotte H, Kalari K, Qin S, Dehm S, Bhargava V, Gormley M, et al.
Mol Cancer Res
. 2022 Sep;
20(12):1739-1750.
PMID: 36135372
Implications: Finally, we identified candidates drugs to reverse AA/P resistance: topoisomerase inhibitors and drugs targeting the cell cycle via the MYC/AURKA/AURKB/TOP2A and/or PI3K_AKT_MTOR pathways.
3.
Cecil D, Curtis B, Gad E, Gormley M, Timms A, Corulli L, et al.
Sci Rep
. 2022 Aug;
12(1):13618.
PMID: 35948756
Prostate cancer is one of the few malignancies that includes vaccination as a treatment modality. Elements of an effective cancer vaccine should include the ability to elicit a Type I...
4.
Smith M, Thomas S, Gormley M, Chowdhury S, Olmos D, Oudard S, et al.
Clin Cancer Res
. 2021 Jun;
27(16):4539-4548.
PMID: 34112710
Purpose: In the placebo-controlled SPARTAN study, apalutamide added to androgen-deprivation therapy (ADT) improved metastasis-free survival, second progression-free survival (PFS2), and overall survival (OS) in patients with nonmetastatic castration-resistant prostate cancer...
5.
Feng F, Thomas S, Saad F, Gormley M, Yu M, Ricci D, et al.
JAMA Oncol
. 2021 Jun;
7(7):1005-1014.
PMID: 34081076
Importance: There is a need to identify prognostic biomarkers to guide treatment intensification in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC). Objective: To examine whether molecular subtypes predict response to...
6.
Gormley M, Aspray T, Kelly D
Indoor Air
. 2021 Feb;
31(5):1427-1440.
PMID: 33569864
Aerosols are readily transported on airstreams through building sanitary plumbing and sewer systems, and those containing microbial pathogens (known as bioaerosols) are recognized as contributors to infection spread within buildings....
7.
Jayaram A, Wingate A, Wetterskog D, Conteduca V, Khalaf D, Taghavi Azar Sharabiani M, et al.
JCO Precis Oncol
. 2020 Sep;
3.
PMID: 32923850
Purpose: Increases in androgen receptor () copy number (CN) can be detected in plasma DNA when patients develop metastatic castration-resistant prostate cancer. We aim to evaluate the association between CN...
8.
9.
Gormley M, Aspray T, Kelly D
Lancet Glob Health
. 2020 Mar;
8(5):e643.
PMID: 32213325
No abstract available.
10.
Gormley M, ONeill D
Front Psychol
. 2019 Jun;
10:1329.
PMID: 31244728
The role of transport in the health and wellbeing of older people is increasingly recognized: driving is the main form of personal transportation across the adult life-span. Patterns of changed...